SCHEMBL6229727

SCHEMBL6229727

CCCC(F)c1cc(N)n(C)n1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4423855 0.73 NOS3 (0.39) ADORA2BGAA
SCHEMBL2678381 0.73 USP2 (0.33) ADORA2BADORA1GAA
SCHEMBL26860530 0.68 ADORA2B (0.30) ADORA2B
SCHEMBL4279839 0.67 IRAK4 (0.30)
SCHEMBL21597737 0.66
SCHEMBL21604128 0.66 NOS3 (0.33) ADORA2B
SCHEMBL7278528 0.64 NOS2 (0.41) ADORA2BADORA1GAA
SCHEMBL4762534 0.64 NOS2 (0.35)
SCHEMBL5223298 0.63
SCHEMBL7272832 0.62 NOS2 (0.44) ADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567517-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Pharmaceuticals Corporation (US) 2005-08-31 EP disclosed
WO-2004050651-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-17 WO disclosed